Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1995-05-24
1998-09-22
Minnifield, Nita
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4241841, 4242581, 4242781, 435 693, 4351721, 4351723, 435243, 435245, 4352523, A61K 3902, A61K 39112, C12N 1500, C12N 100
Patent
active
058111050
ABSTRACT:
An attenuated microorganism harboring two mutated genes, each of which is located in the organisms aromatic pathway is provided. These organisms can usefully form the basis of a vaccine. They can be genetically engineered so as to express antigens from other pathogens and thus form the basis of a range of multi-valent vaccines.
REFERENCES:
patent: 4337314 (1982-06-01), Oeschger et al.
patent: 4535060 (1985-08-01), Comai
patent: 4550081 (1985-10-01), Stocker
patent: 4681762 (1987-07-01), Oeschger et al.
patent: 4735801 (1988-04-01), Stocker
patent: 4837151 (1989-06-01), Stocker
patent: 5356797 (1994-10-01), Niesel et al.
patent: 5527529 (1996-06-01), Dougan et al.
patent: 5599537 (1997-02-01), Miller et al.
Chemical Abstracts 107, 7, p. 194, 53112x "Isolation of stable aroA mutants of Salmonella . . . ".
Chemical Abstracts 106, 25, p. 497, 212119c "Salmonella typhimurium aroA mutants as carriers of . . . ".
Br. J Exper. Path. 32, pp. 85-96, 1951 Bacon et al "The Effects of Biochemical Mutation on the . . . ".
Biological Abstracts 87, 48348 "Construction and Characterization of Vaccine Strains . . . " Dougan et al.
Stocker et al. Vaccine 6, 2, 141-145, Apr. 1988 "Auxotrophic Salmonella typhi . . . ".
Collins et al. J. Exp. Med. 124, 601-619, 1966 "Infection-Immunity in Experimental Salmonellosis".
Collins, Bacter. Rev. 38, 371-402, 1974 "Vaccines and Cell-Mediated Immunity".
Maskell et al., Microb. Pathog. 2, 211-221, 1987 "Salmonella typhimurium aroA Mutants as carriers . . . ".
McFarland et al, Microb. Pathog. 3, 129-141, 1987 "Effect of different purine auxotrophic . . . ".
Dougan et al, Mol. Gen. Genet. 207, 402-405, 1987 "Isolation of stable aroA mutants of Salmonella . . . ".
O'Callaghan et al, Infect. Immun. 56, 419-423, Feb. 1988 "Characterization of Aromatic-and Purine-Dependent . . . ".
Dougan et al . Inf. Dis 158, 1329-1335, Dec. 1988 "Construction and Characterization of Vaccine . . . ".
Pittard, "Biosynthesis of the Aromatic amino Acids:, in Escherichia Coli and Salmonella typhimurium", Cellular and Molecular Biology 1987, 368-394.
Tacket et al "Comparison of the Safety and Immunogenicity of aroC aroD and cya crp Salmonella typhi Strains in Adult Volunteers", Infection and Immunity 60, 536-541, 1992.
Chatfield et al, Vaccine 7 495-498, 1989 "Live Slamonella as vaccines and carriers of foreign antigenic determinants".
Jones et al Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimurium, Vaccine 9, 29-34, Jan. 1991.
Tacket et al "Clinical acceptability and immunogenicity of CVD 908 Sallmonella typhi vaccine strain", Vaccine 10, 443-446, 1992.
Charles, I.G. et al. 1989. Proc. Natl. Acad. Sci. 86:3554-3558.
Hoiseth 1983 Diss. Abs. Int'l 44(2B):413.
Ogino et al. 1982. PNAS, USA 79:5828-32.
Gollub et al. 1967. JBC. 242(22):5323-28.
Chatfield Steven Neville
Dougan Gordon
Hormaeche Carlos Estenio
Glaxo Wellcome Inc.
Minnifield Nita
LandOfFree
Vaccines containing bacteria attenuated by mutations in two gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccines containing bacteria attenuated by mutations in two gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines containing bacteria attenuated by mutations in two gene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1620205